Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.28%
#4 aPriori aPriori +133.46%
#5 Bedrock Bedrock +71.29%
#6 Cysic Cysic +49.09%
#7 Prom Prom +41.40%
#8 Playnance Playnance +35.05%
#9 COTI COTI +29.45%
#10 Bitway Bitway +24.50%
Coin of the day
Wrapped One Wrapped One
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Rangering i aksjer #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Aksjekurs
$0.0009
Sist synkronisert: 2025-05-27
Markedsverdi
$1.15K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Arch Therapeutics, Inc. (ARTH)

Kategori

Healthcare
Antall utestående aksjer for Arch Therapeutics, Inc. (ARTH)
Antall utestående aksjer per June 2024: 4.44M
Ifølge Arch Therapeutics, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 4.44M. Ved slutten av September 2022 hadde selskapet 1.20M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Arch Therapeutics, Inc. (ARTH) fra 2011 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 4.44M 44.57%
2023 3.07M 156.27%
2022 1.20M 9.05%
2021 1.10M 16.99%
2020 940.26K 13.05%
2019 831.70K 8.92%
2018 763.56K 7.00%
2017 713.61K 17.50%
2016 607.31K 49.23%
2015 406.97K 20.60%
2014 337.46K 105.18%
2013 164.48K 482.71%
2012 28.23K -52.21%
2011 59.07K 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 5,612.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,299.20%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR